This article is more than 5 years old. Information may no longer be current.

Forus completes Series B funding for portable screening device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Forus Health Pvt. Ltd. has completed a round of Series B funding of $8.2 million to develop 3nethra, a portable eye screening device, according to a company press release.

The round was led by Asian Healthcare Fund, but was also supported by existing investors, Accel Partners and IDG Ventures India, while Unitus Capital acted as sole advisor to Forus for the transaction, the release said.

Screening with 3nethra can be done quickly, in less than 5 minutes, by persons with minimal training, according to the release. Furthermore, the device can be used in remote areas and the company’s telemedicine application Foruscare can be used to transfer data.

According to the release, the device is in use at 220 sites in 14 countries, and approximately 600,000 eyes have been screened thus far.